Engineering a Human Physiomimetic Islet Microsystem Type 1 diabetes mellitus, an autoimmune disease resulting in destruction of the insulin- producing pancreatic beta cells, is one of the most common and costly chronic pediatric diseases. A significant impediment to understanding disease pathology and the development of cellular replacement therapies for Type 1 diabetes is the inability to sustain mature human beta cells in culture. In this proposal, we seek to engineer physiomimetic 3D niches within microfluidics devices for maturation, maintenance, and monitoring of human beta cells via the convergence of technologies from stem cell biology, matrix engineering, micro/nano fabrication, and microsensors. The microfluidic devices will connect to universal docks and provide intimate control over the cellular microenvironment by independent and simultaneous modulation of liquid and gas phases, multiparameteric monitoring, and assessment of cellular readouts and samplers for off-line biochemical analyses. With this degree of control, the effect of various niche parameters on human islet maintenance and generation of mature islets from human pancreatic precursors can be clearly delineated. Of particular interest in this application are the contributions of the physiological and extracellular matrix environment on islet health and maturation. Physiological oxygen, a critical parameter in steering pancreatic progenitor differentiation towards endocrine lineage, can be intimately modulated on the microscale via the control afforded by the microfabricated platform. Further, systematic evaluation of the contributions of matrix components on promoting islet health and directing islet differentiation within controlled 3D niches is feasible via tailored presentation of native extracellular matrix components. The ultimate goals of this proposal are twofold: 1) engineer a microfabricated """"""""device and dock"""""""" system capable of providing microscale control of soluble and physiological conditions and agile assessment of multiple functional readouts in an enclosed, long-term culture system;and 2) utilize this innovative platform to systematically delineate critical factor capable of supporting both human islet maintenance and maturation of islet-like structures from human pancreatic progenitor cells. The project builds on recent breakthroughs by our team in creating microphysiological systems for other organ systems, engineering perifusion systems, matrix engineering, recreating oxygen controlled microenvironments, and progenitor differentiation. As such, the multidisciplinary consortium assembled herein is well poised to address these grand challenges.
The engineering of ex vivo platforms for the stable culture of islets represents a significant contribution to the field by providing a predictive platform for evaluating pharmaceutical interventions, characterizing immunological responses, and disease modeling. The intimate control of the microenvironment and the incorporation of cellular readouts and samplers for off-line biochemical analyses provided by the platform permits delineation of critical factors necessary for optimal islet health, as well as insight as to the components necessary to promote neo-islet formation from renewable sources. The studies are highly relevant to the mission of the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) and are designed to result in a significant impact on public health.
|Buchwald, Peter; Tamayo-Garcia, Alejandro; Manzoli, Vita et al. (2018) Glucose-stimulated insulin release: Parallel perifusion studies of free and hydrogel encapsulated human pancreatic islets. Biotechnol Bioeng 115:232-245|
|Jiang, K; Chaimov, D; Patel, S N et al. (2018) 3-D physiomimetic extracellular matrix hydrogels provide a supportive microenvironment for rodent and human islet culture. Biomaterials :|
|Garcia-Contreras, Marta; Tamayo-Garcia, Alejandro; Pappan, Kirk L et al. (2017) Metabolomics Study of the Effects of Inflammation, Hypoxia, and High Glucose on Isolated Human Pancreatic Islets. J Proteome Res 16:2294-2306|
|Lenguito, Giovanni; Chaimov, Deborah; Weitz, Jonathan R et al. (2017) Resealable, optically accessible, PDMS-free fluidic platform for ex vivo interrogation of pancreatic islets. Lab Chip 17:772-781|
|Yang, Ethan Y; Kronenfeld, Joshua P; Stabler, Cherie L (2015) Engineering biomimetic materials for islet transplantation. Curr Diabetes Rev 11:163-9|
|Buchwald, Peter; Cechin, Sirlene R; Weaver, Jessica D et al. (2015) Experimental evaluation and computational modeling of the effects of encapsulation on the time-profile of glucose-stimulated insulin release of pancreatic islets. Biomed Eng Online 14:28|
|Ao, Zheng; Parasido, Erika; Rawal, Siddarth et al. (2015) Thermoresponsive release of viable microfiltrated Circulating Tumor Cells (CTCs) for precision medicine applications. Lab Chip 15:4277-82|